Long-term Clinical Outcome of Patients with Severe Combined Immunodeficiency Who Received Related Donor Bone Marrow Transplants without Pretransplant Chemotherapy or Post-transplant GVHD Prophylaxis
To access this article, please choose from the options below
Supported by grants from the National Institute of Allergy and Infectious Diseases (AI042951 and AI47605 ) and a grant from the National Center for Research Resources (NCRR) (#1UL1 RR024128-01), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. The authors declare no conflicts of interest.
PII: S0022-3476(09)00747-1
doi:10.1016/j.jpeds.2009.07.049
© 2009 Mosby, Inc. All rights reserved.
Refers to article:
- Identification of Severe Combined Immunodeficiency by T-Cell Receptor Excision Circles Quantification Using Neonatal Guthrie Cards , 23 July 2009
